The study revealed that the mitochondrial division inhibitor-1 (mdivi-1) increases the sensitivity of ovarian cancer cells to cell surface ligands such as FAS, TRAIL, and TNF-alpha [67]. This evidence concerns the gene TNFSF10 and ovarian carcinoma.